PDF herunterladen
Endoscopy 2008; 40(9): 752-758
DOI: 10.1055/s-2008-1077511
Original article

© Georg Thieme Verlag KG Stuttgart · New York

Evaluation of a novel endoluminal stapling procedure to restrict the lower esophageal sphincter and reduce reflux

E.  Sporn1 , B.  W.  Miedema1 , J.  A.  Astudillo1 , S.  H.  Siddiqi1 , J.  B.  Marshall2 , R.  Calaluce1 , D.  S.  Cleveland3 , T.  S.  Loy3 , K.  Thaler1
  • 1Department of Surgery, University of Missouri, Columbia, USA
  • 2Division of Gastroenterology, University of Missouri, Columbia, USA
  • 3Department of Pathology, University of Missouri, Columbia, USA
Weitere Informationen

Publikationsverlauf

submitted 21 February 2008

accepted after revision 9 July 2008

Publikationsdatum:
04. September 2008 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Siehe auch:

Commentaire de travail de E. Sporn et al., pp. 752Endoscopy 2008; 40(09): 969-969
DOI: 10.1055/s-0032-1306876

Background and study aims: An effective, safe, and long-lasting endoluminal treatment for gastroesophageal reflux disease (GERD) would be an attractive prospect. We developed an endoluminal technique to restrict and tighten the lower esophageal sphincter (LES), by using a transoral endoscopic stapling device in a porcine model.

Patients and methods: Pre-interventional evaluation comprised endoscopy, manometry, and 48-hour pH measurement of the distal esophagus using the catheterless BRAVO pH capsule. By placing the endoluminal stapling device at the LES and firing a 2.5-cm staple line, a vertical plication was created. In five pilot pigs (phase 1), plications were placed in various locations at the LES. In another five pigs (phase 2), plications were placed uniformly at the mid level of the LES on the lesser curvature side. Measurements were repeated 2 weeks after the procedure. Necropsy and histological analysis were performed.

Results: Endoluminal stapling was successfully completed in all animals. In phase 2, the median procedure time was 15 minutes (range 10 – 55 minutes). LES pressure increased from 10.5 mmHg (± 2.5mmHg) to 14.3 mmHg (± 3.8 mmHg) (P = 0.038). Median percentage of time with pH below 4 decreased from 6.6 % (range 2.9 % – 48.8 %) to 2.2 % (range 0 % – 10.4 %) (P = 0.043). Histology showed the staple line involving the muscular layer in all pigs. A gap was present in the central part of the staple line in three pigs resulting in a mucosa-muscular bridge of tissue. This bridge did not influence the results.

Conclusion: This novel endoluminal technique is feasible and safe in a porcine model over 2 weeks. It is appealing due to its simplicity and ease of application. Further studies aimed at eliminating the gap in the staple line and investigating more animals over longer survival periods are needed.

References

  • 1 Fass R, Shapiro M, Dekel R, Sewell J. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease – where next?.  Aliment Pharmacol Ther. 2005;  22 79-94
    PubMedSuche in Google Scholar
  • 2 Mahon D, Rhodes M, Decadt B. et al . Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux.  Br J Surg. 2005;  92 695-699
    CrossrefPubMedSuche in Google Scholar
  • 3 Zaninotto G, Rizzetto C. Surgical options and outcomes in Barrett’s esophagus.  Curr Opin Gastroenterol. 2007;  23 452-455
    CrossrefPubMedSuche in Google Scholar
  • 4 Hofstetter W L, Peters J H, DeMeester T R. et al . Long-term outcome of antireflux surgery in patients with Barrett’s esophagus.  Ann Surg. 2001;  234 532-538; discussion 538 – 539
    CrossrefPubMedSuche in Google Scholar
  • 5 Vakil N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic fundoplication in a U.S. community.  Am J Med. 2003;  114 1-5
    CrossrefPubMedSuche in Google Scholar
  • 6 Morgenthal C B, Lin E, Shane M D. et al . Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-term outcomes.  Surg Endosc. 2007;  21 1978-1984
    CrossrefPubMedSuche in Google Scholar
  • 7 Lenglinger J, Ringhofer C, Eisler M. et al . Diagnosis of Gastroesophageal Reflux Disease (GERD).  European Surgery. 2006;  38 227-243
    CrossrefPubMedSuche in Google Scholar
  • 8 Pandolfino J E, Richter J E, Ours T. et al . Ambulatory esophageal pH monitoring using a wireless system.  Am J Gastroenterol. 2003;  98 740-749
    CrossrefPubMedSuche in Google Scholar
  • 9 Kahrilas P J, Quigley E M. Clinical esophageal pH recording: a technical review for practice guideline development.  Gastroenterology. 1996;  110 1982-1996
    CrossrefPubMedSuche in Google Scholar
  • 10 Johnson L F, DeMeester T R. Development of the 24-hour intraesophageal pH monitoring composite scoring system.  J Clin Gastroenterol. 1986;  8 (Suppl. 1) 52-58
    CrossrefPubMedSuche in Google Scholar
  • 11 Deviere J, Valdes G O, Herrera L C. et al . Safety, feasibility and weight loss after transoral gastroplasty: first human multicenter study.  Surg Endosc. 2008;  22 589-598
    CrossrefPubMedSuche in Google Scholar
  • 12 Kahrilas P J, Lee T J. Gatekeeper reflux repair system; a mechanistic hypothesis.  Gut. 2005;  54 179-180
    CrossrefPubMedSuche in Google Scholar
  • 13 Pandolfino J E, Shi G, Curry J. et al . Esophagogastric junction distensibility: a factor contributing to sphincter incompetence.  Am J Physiol Gastrointest Liver Physiol. 2002;  282 G1052-1058
    CrossrefPubMedSuche in Google Scholar
  • 14 Watson A. An emerging trend in anti-reflux surgery?.  ANZ J Surg. 2001;  71 252
    CrossrefPubMedSuche in Google Scholar
  • 15 Watson A, Jenkinson L R, Ball C S. et al . A more physiological alternative to total fundoplication for the surgical correction of resistant gastro-oesophageal reflux.  Br J Surg. 1991;  78 1088-1094
    CrossrefPubMedSuche in Google Scholar
  • 16 Watson A, Spychal R T, Brown M G. et al . Laparoscopic ’physiological’ antireflux procedure: preliminary results of a prospective symptomatic and objective study.  Br J Surg. 1995;  82 651-656
    CrossrefPubMedSuche in Google Scholar
  • 17 Watson D I, Jamieson G G, Lally C. et al . Multicenter, prospective, double-blind, randomized trial of laparoscopic nissen vs anterior 90 degrees partial fundoplication.  Arch Surg. 2004;  139 1160-1167
    PubMedSuche in Google Scholar
  • 18 Pandolfino J E, Lee T J, Schreiner M A. et al . Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system.  Dis Esophagus. 2006;  19 177-182
    CrossrefPubMedSuche in Google Scholar
  • 19 Liu J J, Glickman J N, Carr-Locke D L. et al . Gastroesophageal junction smooth muscle remodeling after endoluminal gastroplication.  Am J Gastroenterol. 2004;  99 1895-1901
    CrossrefPubMedSuche in Google Scholar
  • 20 Stein H J, Liebermann-Meffert D, DeMeester T R, Siewert J R. Three-dimensional pressure image and muscular structure of the human lower esophageal sphincter.  Surgery. 1995;  117 692-698
    CrossrefPubMedSuche in Google Scholar
  • 21 Pleskow D, Rothstein R, Kozarek R. et al . Endoscopic full-thickness plication for the treatment of GERD: long-term multicenter results.  Surg Endosc. 2007;  21 439-444
    CrossrefPubMedSuche in Google Scholar
  • 22 Schiefke I, Zabel-Langhennig A, Neumann S. et al . Long term failure of endoscopic gastroplication (EndoCinch).  Gut. 2005;  54 752-758
    CrossrefPubMedSuche in Google Scholar
  • 23 Montgomery M, Hakanson B, Ljungqvist O. et al . Twelve months’ follow-up after treatment with the EndoCinch endoscopic technique for gastro-oesophageal reflux disease: a randomized, placebo-controlled study.  Scand J Gastroenterol. 2006;  41 1382-1389
    CrossrefPubMedSuche in Google Scholar
  • 24 Schilling D, Kiesslich R, Galle P R, Riemann J F. Endoluminal therapy of GERD with a new endoscopic suturing device.  Gastrointest Endosc. 2005;  62 37-43
    CrossrefPubMedSuche in Google Scholar
  • 25 Feitoza A B, Gostout C J, Rajan E. et al . Understanding endoluminal gastroplications: a histopathologic analysis of intraluminal suture plications.  Gastrointest Endosc. 2003;  57 868-876
    CrossrefPubMedSuche in Google Scholar
  • 26 Cadiere G B, Rajan A, Germay O, Himpens J. Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study.  Surg Endosc. 2008;  22 333-342
    CrossrefPubMedSuche in Google Scholar
  • 27 Cadiere G B, Rajan A, Rqibate M. et al . Endoluminal fundoplication (ELF)–evolution of EsophyX, a new surgical device for transoral surgery.  Minim Invasive Ther Allied Technol. 2006;  15 348-355
    CrossrefPubMedSuche in Google Scholar
  • 28 Corley D A, Katz P, Wo J M. et al . Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial.  Gastroenterology. 2003;  125 668-676
    CrossrefPubMedSuche in Google Scholar
  • 29 Triadafilopoulos G, DiBaise J K, Nostrant T T. et al . The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial.  Gastrointest Endosc. 2002;  55 149-156
    CrossrefPubMedSuche in Google Scholar
  • 30 FDA preliminary public health notification: recall of Boston Scientific Enteryx procedure kits and Enteryx injector single packs for treatment of gastroesophageal reflux disease (GERD). http://www.fda. gov/cdrh/safety/101405-enteryx.html. Accessed October 25, 2006. 
  • 31 Noh K W, Loeb D S, Stockland A, Achem S R. Pneumomediastinum following Enteryx injection for the treatment of gastroesophageal reflux disease.  Am J Gastroenterol. 2005;  100 723-726
    CrossrefPubMedSuche in Google Scholar
  • 32 Tintillier M, Chaput A, Kirch L. et al . Esophageal abscess complicating endoscopic treatment of refractory gastroesophageal reflux disease by Enteryx injection: a first case report.  Am J Gastroenterol. 2004;  99 1856-1858
    CrossrefPubMedSuche in Google Scholar
  • 33 Wong R F, Davis T V, Peterson K A. Complications involving the mediastinum after injection of Enteryx for GERD.  Gastrointest Endosc. 2005;  61 753-756
    CrossrefPubMedSuche in Google Scholar

B. W. Miedema, MD 

Department of Surgery
University of Missouri

One Hospital Drive

Columbia, MO 65212
USA

Fax: +1-573-884-5049

eMail: miedemab@health.missouri.edu